up protherics
07 Mar 2015
Results Has anyone any idea as to when the finals will be posted..Here;s hoping that things are starting to gel and future sales look promising. It would be nice if this could get to the £1 level
Carefully Does It
11 Feb 2015
Re: My Guess I reckon CRX are working with TAKEDA.It has all the hallmarks of the one to target in Japan and if so is a very useful cusotmer.
up protherics
11 Feb 2015
Re: My Guess I cant see how any merger would take place.. For one SBS are 3 times bigger.If anything they would take CRX over at I would imagine 1.20 or more ..Its a bit sad really with the current positive news emanating from the anti animal testing lobby.
Carefully Does It
11 Feb 2015
Re: My Guess Would have to be at 120p+ for Baxter.Say 30% premium to market price, 90p before it kicks off?
Ambiorix1
11 Feb 2015
Re: My Guess My guess is more pragmatic. Going back in time one will find out that the conversion rate for the loan notes was 6 p. Since the more recent consolidation of the shares, this conversion rate became 60 p. Since main shareholders of Cypro and main holders of the loan notes are to be considered as much linked to each other, the intrinsic value of Cypro IMO is at least 60 p. especially if there is a deal up hand (a bid or a merger) which seems plausible to me. I think some astute investors noticed this undervaluation, which explains the recent rise of the SP despite the small trading volumes and despite the fact that there is no other news which could explain this rise. My bet remains a merger with SBS.Ambiorix.
Carefully Does It
10 Feb 2015
Re: My Guess Still expecting a deal out of Japan.
up protherics
10 Feb 2015
Re: My Guess It could also have something to do with the current high profile conferences calling for a ban on animal testing which seems to be gathering pace worlwid
up protherics
10 Feb 2015
My Guess My guess as to why the share has been moving positively is due to...End of results better than expected due to an adjustment in the balance sheet of about 800,000 ( credit down to the share price being below 60 p at year end.) Convertible and loan note charge reversed.Also the exchange rate against the dollar has also been attractive and together with a possible increase in revenue for the last couple of months of the year the results on the face of it should look quite impressive.
vandeheide
10 Feb 2015
reason for SP increase does anybody have an idea as to the reason for the upturn in the SP? No RNS and low volume!The SP shot up last year in Feb too!
Carefully Does It
06 Feb 2015
Re: Recent Rise... perhaps this... i read it that part of the reason for the way the money was raised was to protect the company from a cheeky predator picking up the assets before crx had chance to reach appropriate value.ceo compensation geared to 120p too.all who criticise the co. probably are short termers.crx has a very bright future if you invest 3-5 yrs out.have to trust mgt to execute but that's the same in any investment.
Carefully Does It
05 Feb 2015
Re: Recent Rise... perhaps this... what would they do with the loan note holders?
Ambiorix1
05 Feb 2015
Recent Rise... perhaps this... Last weekend I scrolled trough the discussions on the SBS board and I noticed on 7/08/2012 Biswell 2 made this statement:"….I have urged the SBS BOD several times over the last two years to speak to the Cyprotex BOD regarding forming a strategic alliance similar to other strategic alliances that Cyprotex have entered into in recently with other small companies whereby BOTH companies benefit by exposing their clients to ADDITIONAL services/offerings that they do not offer themselves .... on an agreed percentage basis. In this way BOTH companies gain an additional revenue stream that they would not otherwise benefit from PLUS .... there is the opportunity to gain NEW clients for other services/offerings resulting from this exposure that would have never had occurred without the alliance agreement.Why is Cyprotex is my preference for SBS to align themselves with ?1. Cyprotex are now a world leader in the CRO ADME Tox arena , which is why increasingly other firms are forming strategic alliances to gain access to their INCREASING list of clients NOW OVER 700.2. Source Bioscience have no exposure in North America other than an agent selling LifeSciences consumables ie Clones , Antibodies etc. The USA is the BIGGEST place to be IN THE WORLD for Pharma Biotech work ..... SBS have ZIP exposure ..... NOT GOOD.3. Cyprotex through it's acquisition of Apredica now have a secure base of operations in Boston the MAJOR USA East coast hub of the American Pharma Biotech Industry. End of quote.We are now a few years later and I noticed this coincidence, ... or is it not a coincidence:Main shareholders Cyprotex : Harwood Capital 28.3%, Hargreave Hale 9.97% and Henderson Global 6.95%. All of these are linked to Christopher Mills.Main shareholders SBS : Henderson Global 17.16%, Harwood Capital 11.6%, Hargreave Hale 3.83% and Oryx 11%. All are linked to Christopher Mills.Over the last few weeks, we have seen heavy trades in SBS (Oryx keeps buying and Richard Griffith is joining the party) and recent buys by directors of CYPRO.Is there at last a merger of both coming?In my opinion it could be a nice fit, don't you think so.
Carefully Does It
04 Feb 2015
Re: Recent Rise I think it will be fine.They have good services, best equipment with high throughput capability and have worked on increasing geographic spread and market segments served.Time now needed to see it come together.
up protherics
04 Feb 2015
Recent Rise Any one any idea as to why the share has risen recently on no/ little volume. The last time this happened we had a trading statement with a 20% fall in value.. I may be a pessimist , but past history doesn't bode well im
up protherics
12 Dec 2014
Convertable question Doe anyone know if the convertables automatically convert on redemption day. Or does the loan become repayable without conversion.If that's the case then its much more beneficial for the share price to remain low until redemption day.
